Cargando…

What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis

BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya...

Descripción completa

Detalles Bibliográficos
Autores principales: Türkyılmaz, Zeliha, Demirel, Tuğrul, Cakcak, İbrahim Ethem, Aytin, Yusuf Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644090/
https://www.ncbi.nlm.nih.gov/pubmed/37791437
http://dx.doi.org/10.14744/tjtes.2023.06486
_version_ 1785147198355275776
author Türkyılmaz, Zeliha
Demirel, Tuğrul
Cakcak, İbrahim Ethem
Aytin, Yusuf Emre
author_facet Türkyılmaz, Zeliha
Demirel, Tuğrul
Cakcak, İbrahim Ethem
Aytin, Yusuf Emre
author_sort Türkyılmaz, Zeliha
collection PubMed
description BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya University Faculty of Medicine between March 15, 2019 and March 15, 2021 were retrospectively recruited. Patients were classified as pre-COVID and COVID-era patients. The comorbidity markers, data from laboratory tests, inflammatory markers, and radiological examinations were evaluated. Length of stay, need for an intensive care unit, morbidity, mortality, recurrent ABP, and definitive treatment rates were evaluated, and the data of the two periods were compared. RESULTS: Two groups of patients, 57 in the pre-COVID period and 34 in the COVID period, were included in the study. We found that ABP admissions decreased significantly during periods of increased national COVID-19 diagnoses. Type 2 diabetes mellitus was significantly higher in the COVID period patients (P=0.044), and COVID patients had significantly higher total (P=0.004), direct bilirubin (P=0.007), and lipases (P<0.001). The cholecystectomy rate after an attack decreased from 26% in the pre-COVID period to 15.6% during COVID. CONCLUSION: COVID strikingly reduced the admissions of ABP patients in the early stages of the disease to hospitals, leading to inevitable admissions in advanced severity. Moreover, a significant increase was detected in the recurrence rates of ABP. This can be explained by the reduction in cholecystectomy performed.
format Online
Article
Text
id pubmed-10644090
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-106440902023-11-15 What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis Türkyılmaz, Zeliha Demirel, Tuğrul Cakcak, İbrahim Ethem Aytin, Yusuf Emre Ulus Travma Acil Cerrahi Derg Original Article BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya University Faculty of Medicine between March 15, 2019 and March 15, 2021 were retrospectively recruited. Patients were classified as pre-COVID and COVID-era patients. The comorbidity markers, data from laboratory tests, inflammatory markers, and radiological examinations were evaluated. Length of stay, need for an intensive care unit, morbidity, mortality, recurrent ABP, and definitive treatment rates were evaluated, and the data of the two periods were compared. RESULTS: Two groups of patients, 57 in the pre-COVID period and 34 in the COVID period, were included in the study. We found that ABP admissions decreased significantly during periods of increased national COVID-19 diagnoses. Type 2 diabetes mellitus was significantly higher in the COVID period patients (P=0.044), and COVID patients had significantly higher total (P=0.004), direct bilirubin (P=0.007), and lipases (P<0.001). The cholecystectomy rate after an attack decreased from 26% in the pre-COVID period to 15.6% during COVID. CONCLUSION: COVID strikingly reduced the admissions of ABP patients in the early stages of the disease to hospitals, leading to inevitable admissions in advanced severity. Moreover, a significant increase was detected in the recurrence rates of ABP. This can be explained by the reduction in cholecystectomy performed. Kare Publishing 2023-09-08 /pmc/articles/PMC10644090/ /pubmed/37791437 http://dx.doi.org/10.14744/tjtes.2023.06486 Text en Copyright © 2023 Turkish Journal of Trauma and Emergency Surgery https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Türkyılmaz, Zeliha
Demirel, Tuğrul
Cakcak, İbrahim Ethem
Aytin, Yusuf Emre
What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title_full What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title_fullStr What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title_full_unstemmed What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title_short What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
title_sort what has changed? the impact of the covid-19 pandemic on the management of acute biliary pancreatitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644090/
https://www.ncbi.nlm.nih.gov/pubmed/37791437
http://dx.doi.org/10.14744/tjtes.2023.06486
work_keys_str_mv AT turkyılmazzeliha whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis
AT demireltugrul whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis
AT cakcakibrahimethem whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis
AT aytinyusufemre whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis